EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Quantitative Evaluation of COVID-19 Pneumonia CT Using AI Analysis—Feasibility and Differentiation from Other Common Pneumonia Forms

Una Ebong, Susanne Martina Büttner, Stefan A Schmidt iD, Franziska Flack, Patrick Korf, Lynn Peters iD, Beate Grüner iD, Steffen Stenger, Thomas Stamminger iD, Hans Kestler iD, Meinrad Beer iD, Christopher Kloth

Diagnostics · 20.06.2023 · 13 (12) · 2129

DOI: 10.3390/diagnostics13122129 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diagnostics, online erschienen am 20.06.2023. Verfasst von Una Ebong und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic and Interventional Radiology, Ulm University Medical Center, Albert-Einstein-Allee 23, 89081 Ulm, Germany. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Federal Ministry of Education and Research (BMBF) as part of the University Medicine Network 2.0.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To implement the technical feasibility of an AI-based software prototype optimized for the detection of COVID-19 pneumonia in CT datasets of the lung and the differentiation between other etiologies of pneumonia. METHODS: This single-center retrospective case–control-study consecutively yielded 144 patients (58 female, mean age 57.72 ± 18.25 y) with CT datasets of the lung. Subgroups including confirmed bacterial (n = 24, 16.6%), viral (n = 52, 36.1%), or fungal (n = 25, 16.6%) pneumonia and (n = 43, 30.7%) patients without detected pneumonia (comparison group) were evaluated using the AI-based Pneumonia Analysis prototype. Scoring (extent, etiology) was compared to reader assessment. RESULTS: The software achieved an optimal sensitivity of 80.8% with a specificity of 50% for the detection of COVID-19; however, the human radiologist achieved optimal sensitivity of 80.8% and a specificity of 97.2%. The mean postprocessing time was 7.61 ± 4.22 min. The use of a contrast agent did not influence the results of the software (p = 0.81). The mean evaluated COVID-19 probability is 0.80 ± 0.36 significantly higher in COVID-19 patients than in patients with fungal pneumonia (p < 0.05) and bacterial pneumonia (p < 0.001). The mean percentage of opacity (PO) and percentage of high opacity (PHO ≥ −200 HU) were significantly higher in COVID-19 patients than in healthy patients. However, the total mean HU in COVID-19 patients was −679.57 ± 112.72, which is significantly higher than in the healthy control group (p < 0.001). CONCLUSION: The detection and quantification of pneumonia beyond the primarily trained COVID-19 datasets is possible and shows comparable results for COVID-19 pneumonia to an experienced reader. The advantages are the fast, automated segmentation and quantification of the pneumonia foci.

Schlagwörter

Stichwörter der Autor:innen

COVID-19 pneumoniaCTautomated segmentation and quantification

Autor:innen und Institutionen

  • Department of Diagnostic and Interventional Radiology, Ulm University Medical Center, Albert-Einstein-Allee 23, 89081 Ulm, Germany.
  • Scientific Collaborations Siemens Healthcare GmbH Erlangen, 91052 Erlangen, Germany.
  • Division of Infectious Diseases, University Hospital and Medical Centre of Ulm, 89081 Ulm, Germany.
  • Institute of Medical Microbiology and Hygiene, Ulm University Medical Center, 89081 Ulm, Germany.
  • Institute of Virology, Ulm University Medical Center, 89081 Ulm, Germany.
  • Institute for Medical Systems Biology, Ulm University, 89081 Ulm, Germany.

ORCID-Profile: Stefan A Schmidt, Lynn Peters, Beate Grüner, Thomas Stamminger, Hans Kestler, Meinrad Beer

Förderung

  • German Federal Ministry of Education and Research (BMBF) as part of the University Medicine Network 2.0

Zitieren

APA

Ebong, U., Büttner, S. M., Schmidt, S. A., Flack, F., Korf, P., Peters, L., Grüner, B., Stenger, S., Stamminger, T., Kestler, H., Beer, M., & Kloth, C. (2023). Quantitative Evaluation of COVID-19 Pneumonia CT Using AI Analysis—Feasibility and Differentiation from Other Common Pneumonia Forms. Diagnostics, 13(12), 2129. https://doi.org/10.3390/diagnostics13122129

Vancouver

Ebong U, Büttner SM, Schmidt SA, Flack F, Korf P, Peters L, et al. Quantitative Evaluation of COVID-19 Pneumonia CT Using AI Analysis—Feasibility and Differentiation from Other Common Pneumonia Forms. Diagnostics. 2023;13(12):2129. doi:10.3390/diagnostics13122129

BibTeX
@article{Ebong2023,
  author = {Ebong, Una and Büttner, Susanne Martina and Schmidt, Stefan A and Flack, Franziska and Korf, Patrick and Peters, Lynn and Grüner, Beate and Stenger, Steffen and Stamminger, Thomas and Kestler, Hans and Beer, Meinrad and Kloth, Christopher},
  title = {Quantitative Evaluation of COVID-19 Pneumonia CT Using AI Analysis—Feasibility and Differentiation from Other Common Pneumonia Forms},
  journal = {Diagnostics},
  year = {2023},
  volume = {13},
  number = {12},
  pages = {2129},
  doi = {10.3390/diagnostics13122129}
}
Kostenlos starten →